Trupanion, Inc. (NASDAQ:TRUP – Free Report) – Stock analysts at William Blair dropped their Q1 2025 earnings per share estimates for Trupanion in a research report issued on Thursday, February 20th. William Blair analyst B. Vazquez now anticipates that the financial services provider will post earnings per share of ($0.06) for the quarter, down from their previous forecast of ($0.03). The consensus estimate for Trupanion’s current full-year earnings is $0.13 per share. William Blair also issued estimates for Trupanion’s Q2 2025 earnings at ($0.03) EPS, Q1 2026 earnings at ($0.02) EPS and Q2 2026 earnings at ($0.02) EPS.
Several other equities research analysts have also recently commented on TRUP. Northland Securities lifted their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Stifel Nicolaus lowered their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Finally, Piper Sandler cut their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
Trupanion Stock Performance
Trupanion stock opened at $33.41 on Monday. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The stock has a 50-day simple moving average of $47.64 and a 200 day simple moving average of $48.06. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $1.41 billion, a price-to-earnings ratio of -145.26, a P/E/G ratio of 6.02 and a beta of 1.60.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%.
Institutional Trading of Trupanion
Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its position in Trupanion by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock valued at $173,362,000 after buying an additional 45,653 shares during the last quarter. Wellington Management Group LLP grew its position in Trupanion by 4.4% in the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after purchasing an additional 142,156 shares in the last quarter. FMR LLC increased its stake in Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares during the last quarter. Marshall Wace LLP lifted its position in Trupanion by 6.9% during the 4th quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock worth $43,459,000 after buying an additional 57,804 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its stake in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after buying an additional 661,559 shares during the last quarter.
Insider Buying and Selling
In other news, CFO Fawwad Qureshi sold 9,867 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $53.08, for a total value of $523,740.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 5.50% of the stock is owned by company insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- 10 Best Airline Stocks to Buy
- Finding Hidden Gems: Unconventional Penny Stock Investing
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Price Targets on NVIDIA Rise in Front of Earnings
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.